tetano
Editor, Senior Moderator
J Clin Med
. 2020 Oct 26;9(11):E3441.
doi: 10.3390/jcm9113441.
COVID-19 and Adverse Pregnancy Outcome: A Systematic Review of 104 Cases
Ramy Abou Ghayda[SUP] 1 2 [/SUP], Han Li[SUP] 3 [/SUP], Keum Hwa Lee[SUP] 4 [/SUP], Hee Won Lee[SUP] 4 [/SUP], Sung Hwi Hong[SUP] 1 4 [/SUP], Moonsu Kwak[SUP] 4 [/SUP], Minwoo Lee[SUP] 4 [/SUP], Minjae Kwon[SUP] 4 [/SUP], Ai Koyanagi[SUP] 5 6 [/SUP], Andreas Kronbichler[SUP] 7 [/SUP], Louis Jacob[SUP] 5 8 [/SUP], Lee Smith[SUP] 9 [/SUP], Jae Il Shin[SUP] 4 [/SUP]
Affiliations
Abstract
(1) Background: Until now, several reports about pregnant women with confirmed coronavirus disease 2019 (COVID-19) have been published. However, there are no comprehensive systematic reviews collecting all case series studies on data regarding adverse pregnancy outcomes, especially association with treatment modalities. (2) Objective: We aimed to synthesize the most up-to-date and relevant available evidence on the outcomes of pregnant women with laboratory-confirmed infection with COVID-19. (3) Methods: PubMed, Scopus, MEDLINE, Google scholar, and Embase were explored for studies and papers regarding pregnant women with COVID-19, including obstetrical, perinatal, and neonatal outcomes and complications published from 1 January 2020 to 4 May 2020. Systematic review and search of the published literature was done using the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA). (4) Results: In total, 11 case series studies comprising 104 pregnant women with COVID-19 were included in our review. Fever (58.6%) and cough (30.7%) were the most common symptoms. Other symptoms included dyspnea (14.4%), chest discomfort (3.9%), sputum production (1.0%), sore throat (2.9%), and nasal obstruction (1.0%). Fifty-two patients (50.0%) eventually demonstrated abnormal chest CT, and of those with ground glass opacity (GGO), 23 (22.1%) were bilateral and 10 (9.6%) were unilateral. The most common treatment for COVID-19 was administration of antibiotics (25.9%) followed by antivirals (17.3%). Cesarean section was the mode of delivery for half of the women (50.0%), although no information was available for 28.8% of the cases. Regarding obstetrical and neonatal outcomes, fetal distress (13.5%), pre-labor rupture of membranes (9.6%), prematurity (8.7%), fetal death (4.8%), and abortion (2.9%) were reported. There are no positive results of neonatal infection by RT-PCR. (5) Conclusions: Although we have found that pregnancy with COVID-19 has significantly higher maternal mortality ratio compared to that of pregnancy without the disease, the evidence is too weak to state that COVID-19 results in poorer maternal outcome due to multiple factors. The number of COVID-19 pregnancy outcomes was not large enough to draw a conclusion and long-term outcomes are yet to be determined as the pandemic is still unfolding. Active and intensive follow-up is needed in order to provide robust data for future studies.
Keywords: COVID-19; SARS-CoV-2; coronavirus disease 2019; fetal death; maternal morbidity; maternal mortality; neonatal morbidity; neonatal mortality; neonatal outcomes; pregnancy; preterm birth; stillbirth.
. 2020 Oct 26;9(11):E3441.
doi: 10.3390/jcm9113441.
COVID-19 and Adverse Pregnancy Outcome: A Systematic Review of 104 Cases
Ramy Abou Ghayda[SUP] 1 2 [/SUP], Han Li[SUP] 3 [/SUP], Keum Hwa Lee[SUP] 4 [/SUP], Hee Won Lee[SUP] 4 [/SUP], Sung Hwi Hong[SUP] 1 4 [/SUP], Moonsu Kwak[SUP] 4 [/SUP], Minwoo Lee[SUP] 4 [/SUP], Minjae Kwon[SUP] 4 [/SUP], Ai Koyanagi[SUP] 5 6 [/SUP], Andreas Kronbichler[SUP] 7 [/SUP], Louis Jacob[SUP] 5 8 [/SUP], Lee Smith[SUP] 9 [/SUP], Jae Il Shin[SUP] 4 [/SUP]
Affiliations
- PMID: 33114779
- DOI: 10.3390/jcm9113441
Abstract
(1) Background: Until now, several reports about pregnant women with confirmed coronavirus disease 2019 (COVID-19) have been published. However, there are no comprehensive systematic reviews collecting all case series studies on data regarding adverse pregnancy outcomes, especially association with treatment modalities. (2) Objective: We aimed to synthesize the most up-to-date and relevant available evidence on the outcomes of pregnant women with laboratory-confirmed infection with COVID-19. (3) Methods: PubMed, Scopus, MEDLINE, Google scholar, and Embase were explored for studies and papers regarding pregnant women with COVID-19, including obstetrical, perinatal, and neonatal outcomes and complications published from 1 January 2020 to 4 May 2020. Systematic review and search of the published literature was done using the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA). (4) Results: In total, 11 case series studies comprising 104 pregnant women with COVID-19 were included in our review. Fever (58.6%) and cough (30.7%) were the most common symptoms. Other symptoms included dyspnea (14.4%), chest discomfort (3.9%), sputum production (1.0%), sore throat (2.9%), and nasal obstruction (1.0%). Fifty-two patients (50.0%) eventually demonstrated abnormal chest CT, and of those with ground glass opacity (GGO), 23 (22.1%) were bilateral and 10 (9.6%) were unilateral. The most common treatment for COVID-19 was administration of antibiotics (25.9%) followed by antivirals (17.3%). Cesarean section was the mode of delivery for half of the women (50.0%), although no information was available for 28.8% of the cases. Regarding obstetrical and neonatal outcomes, fetal distress (13.5%), pre-labor rupture of membranes (9.6%), prematurity (8.7%), fetal death (4.8%), and abortion (2.9%) were reported. There are no positive results of neonatal infection by RT-PCR. (5) Conclusions: Although we have found that pregnancy with COVID-19 has significantly higher maternal mortality ratio compared to that of pregnancy without the disease, the evidence is too weak to state that COVID-19 results in poorer maternal outcome due to multiple factors. The number of COVID-19 pregnancy outcomes was not large enough to draw a conclusion and long-term outcomes are yet to be determined as the pandemic is still unfolding. Active and intensive follow-up is needed in order to provide robust data for future studies.
Keywords: COVID-19; SARS-CoV-2; coronavirus disease 2019; fetal death; maternal morbidity; maternal mortality; neonatal morbidity; neonatal mortality; neonatal outcomes; pregnancy; preterm birth; stillbirth.